---
title: "Aosaikang: The results of the Phase III clinical study of Liraglutide Tablets were published in The Lancet Respiratory Medicine"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/245659120.md"
description: "Aosaikang announced that the Phase III clinical research results of its innovative drug Liratinib tablets were recently published in the international top medical journal The Lancet Respiratory Medicine. Liratinib tablets are third-generation epidermal growth factor receptor tyrosine kinase inhibitors used for first-line and second-line treatment of adult patients with locally advanced or metastatic non-small cell lung cancer with EGFR mutations"
datetime: "2025-06-23T09:03:19.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/245659120.md)
  - [en](https://longbridge.com/en/news/245659120.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/245659120.md)
---

# Aosaikang: The results of the Phase III clinical study of Liraglutide Tablets were published in The Lancet Respiratory Medicine

Aosaikang announced that the Phase III clinical research results of its innovative drug Liratinib tablets were recently published in the international top medical journal The Lancet Respiratory Medicine. Liratinib tablets are third-generation epidermal growth factor receptor tyrosine kinase inhibitors used for first-line and second-line treatment of adult patients with locally advanced or metastatic non-small cell lung cancer with EGFR mutations

### Related Stocks

- [300361.CN](https://longbridge.com/en/quote/300361.CN.md)
- [002755.CN](https://longbridge.com/en/quote/002755.CN.md)

## Related News & Research

- [US probing if China firms cut output of containers before pandemic, says CBS](https://longbridge.com/en/news/286944311.md)
- [Coffee Prices Rebound on Technical Short-Covering](https://longbridge.com/en/news/286941721.md)
- [Should You Be Adding Daewoong Pharmaceutical (KRX:069620) To Your Watchlist Today?](https://longbridge.com/en/news/286824214.md)
- [14:47 ET6th Annual Midwest Design Awards Entry Period Now Open](https://longbridge.com/en/news/286808240.md)
- [Dunkin' To Give Away 1 Mln Free Coffees For A Day](https://longbridge.com/en/news/286964019.md)